Sinophi Taps Burgeoning China Proton Therapy Market In Multiple Deals
This article was originally published in PharmAsia News
Executive Summary
The UK’s Sinophi Healthcare is taking a big leap into cancer treatment in China through a foray to build multiple proton centers, adding to the rapidly rising competition in the sector. No such therapy was offered in the country until June, but now multiple facilities are in the works amid steadily increasing cancer incidence.